Otolaryngology, Respiratory, and Allergic
Bronchiolitis in Children
January 2003
Clinical Focus*
- What is the effectiveness and relative effectiveness of appropriate diagnostic tools for diagnosing bronchiolitis in infants and children?
- What is the efficacy or effectiveness of pharmaceutical therapies for treating bronchiolitis among infants and children? Does the evidence show that any single agent (or any single antimicrobial) is the most effective in improving outcomes?
- What is the role of prophylactic therapy for prevention of bronchiolitis among children? Are there any specific subpopulations within this group who would benefit from such prophylaxis?
- What is the evidence concerning the cost-effectiveness of prophylactic therapy for prevention of bronchiolitis among premature infants?
*Addressed in the summary or evidence report.
Management of Bronchiolitis in Infants and Children
Summary (Publication No. 03-E009, January 2003)
Evidence Report (Publication No. 03-E014, January 2003)
(PDF Files; File Download)
EPC: Research Triangle Institute/UNC-CH
Topic Nominators: American Academy of Pediatrics. American Academy of Family Physicians
Return to Quick Menu: Evidence Report Topics
Return to Evidence-based Practice